UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.86B |
| 2 |
Prologis
PLD
|
+$1.82B |
| 3 |
Welltower
WELL
|
+$1.61B |
| 4 |
Microsoft
MSFT
|
+$1.53B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Realty Trust
DLR
|
+$822M |
| 2 |
AutoZone
AZO
|
+$481M |
| 3 |
Extra Space Storage
EXR
|
+$300M |
| 4 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$284M |
| 5 |
Meta Platforms (Facebook)
META
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.15% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.43% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Hamilton Insurance Group
HG
$3.59B
| $2.19M | ﹤0.01% |
73,530
+7,404
| +11% | +$213K |
|
2002
Amylyx Pharmaceuticals
AMLX
$2.05B
| $2.18M | ﹤0.01% |
157,089
+58,251
| +59% | +$819K |
|
2003
Amalgamated Financial
AMAL
$1.48B
| $2.18M | ﹤0.01% |
56,128
+234
| +0.4% | +$8.87K |
|
|
EFC
2004
Ellington Financial
EFC
$1.68B
| $2.18M | ﹤0.01% |
183,693
+20,895
| +13% | +$266K |
|
2005
TripAdvisor
TRIP
$1.59B
| $2.17M | ﹤0.01% |
203,144
+11,251
| +6% | +$131K |
|
2006
Mineralys Therapeutics
MLYS
$2.35B
| $2.15M | ﹤0.01% |
79,537
+3,640
| +5% | +$107K |
|
2007
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $2.14M | ﹤0.01% |
44,525
+2,123
| +5% | +$94K |
|
2008
Atour Lifestyle Holdings
ATAT
$4.35B
| $2.14M | ﹤0.01% |
58,152
| – | – |
|
2009
NCR Voyix
VYX
$1.06B
| $2.14M | ﹤0.01% |
337,919
+8,720
| +3% | +$77K |
|
|
SCHR
2010
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
| $2.13M | ﹤0.01% |
85,612
+70,089
| +452% | +$1.76M |
|
2011
Vanguard Communication Services ETF
VOX
$5.53B
| $2.13M | ﹤0.01% |
11,858
+9,429
| +388% | +$1.79M |
|
2012
Ingles Markets
IMKTA
$1.63B
| $2.13M | ﹤0.01% |
23,684
+1,717
| +8% | +$139K |
|
2013
Novavax
NVAX
$1.23B
| $2.13M | ﹤0.01% |
261,266
+12,277
| +5% | +$111K |
|
|
HDV
2014
iShares Core High Dividend ETF
HDV
$14.4B
| $2.12M | ﹤0.01% |
78,045
+69,350
| +798% | +$1.85M |
|
2015
Vanguard Small-Cap Growth ETF
VBK
$23.2B
| $2.1M | ﹤0.01% |
6,949
+4,847
| +231% | +$1.52M |
|
2016
Relay Therapeutics
RLAY
$4.02B
| $2.09M | ﹤0.01% |
210,468
+620
| +0.3% | +$5.55K |
|
2017
J&J Snack Foods
JJSF
$1.43B
| $2.09M | ﹤0.01% |
26,396
+265
| +1% | +$22.9K |
|
2018
iShares Core S&P US Value ETF
IUSV
$27.2B
| $2.09M | ﹤0.01% |
20,441
+18,466
| +935% | +$1.94M |
|
2019
GeoPark
GPRK
$649M
| $2.09M | ﹤0.01% |
219,815
| – | – |
|
2020
AMN Healthcare
AMN
$1.28B
| $2.08M | ﹤0.01% |
113,340
+18,641
| +20% | +$354K |
|
2021
Appian
APPN
$1.74B
| $2.07M | ﹤0.01% |
86,000
+2,085
| +2% | +$56.6K |
|
2022
C3.ai
AI
$1.27B
| $2.07M | ﹤0.01% |
245,965
+10,646
| +5% | +$114K |
|
2023
Sable Offshore Corp
SOC
$903M
| $2.07M | ﹤0.01% |
125,362
-35,180
| -22% | -$411K |
|
2024
JetBlue
JBLU
$1.96B
| $2.06M | ﹤0.01% |
466,696
-463,091
| -50% | -$2.35M |
|
2025
Turning Point Brands
TPB
$1.47B
| $2.06M | ﹤0.01% |
23,699
+617
| +3% | +$68.8K |
|
Similar funds
UBS AM's Q1 2026 Portfolio in Review
As of Q1 2026, UBS AM held 3,871 positions worth $481B, up 1.7% from $473B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
UBS AM deployed $35.5B of net new capital in Q1 2026, opening 584 new positions and adding to 2,429 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Digital Realty Trust, an estimated $822M trimmed.
- UBS AM's largest Q1 2026 buy was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
- UBS AM added most to Broadcom in Q1 2026, an estimated $1.86B increase.
- UBS AM's biggest Q1 2026 reduction was Digital Realty Trust, cutting an estimated $822M.
- UBS AM fully exited CyberArk in Q1 2026, selling an estimated $139M.
- UBS AM's ten largest holdings make up 32% of its $481B portfolio in Q1 2026.
- UBS AM opened 584 new positions and closed 64 in Q1 2026.
- UBS AM's portfolio value rose 1.7% quarter-over-quarter to $481B.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.